Bombay Super Hybrid Seeds IPO vs Dr Lalchandani Labs IPO

Comparison between Bombay Super Hybrid Seeds IPO and Dr Lalchandani Labs IPO.

IPO Details

Bombay Super Hybrid Seeds IPO is a SME Fixed Price IPO proposed to list at NSE SME while Dr Lalchandani Labs IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Bombay Super Hybrid Seeds IPO is up to ₹9.86 Cr whereas the issue size of the Dr Lalchandani Labs IPO is up to ₹3.98 Cr. The final issue price of Bombay Super Hybrid Seeds IPO is ₹60.00 per share and of Dr Lalchandani Labs IPO is ₹30.00 per share.

 Bombay Super Hybrid Seeds IPODr Lalchandani Labs IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final)₹60.00 per share₹30.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Discount (Employee)
Market Lot Size2000 shares4000 shares
Fresh Issue Size16,44,000 shares13,28,000 shares
Fresh Issue Size (Amount)up to ₹9.86 Crup to ₹3.98 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total16,44,000 shares13,28,000 shares
Issue Size Total (Amount)up to ₹9.86 Crup to ₹3.98 Cr

IPO Timetable

Bombay Super Hybrid Seeds IPO opens on Apr 12, 2018, while Dr Lalchandani Labs IPO opens on Apr 25, 2018. The closing date of Bombay Super Hybrid Seeds IPO and Dr Lalchandani Labs IPO is Apr 17, 2018, and Apr 27, 2018, respectively.

Financials & KPIs

Bombay Super Hybrid Seeds IPO P/E ratio is , as compared to Dr Lalchandani Labs IPO P/E ratio of .

 Bombay Super Hybrid Seeds IPODr Lalchandani Labs IPO
Financials

Company Financials ()

Period Ended
Amount in ₹ Crore

Company Financials ()

Period Ended
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap₹39.35 Cr.₹13.00 Cr.
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Bombay Super Hybrid Seeds IPO Retail Individual Investors (RII) are offered 8,22,000 shares while in Dr Lalchandani Labs IPO retail investors are offered 8,22,000 shares. Qualified Institutional Buyers (QIB) are offered in Bombay Super Hybrid Seeds IPO and in Dr Lalchandani Labs IPO.

 Bombay Super Hybrid Seeds IPODr Lalchandani Labs IPO
Anchor Investor Reservation
Market Maker Reservation88,000 shares72,000 shares
QIB
NII8,22,000 shares6,64,000 shares
RII8,22,000 shares6,64,000 shares
Employee
Others
Total16,44,000 shares13,28,000 shares

Bids Received (Subscription)

Bombay Super Hybrid Seeds IPO subscribed 9.50x in total, whereas Dr Lalchandani Labs IPO subscribed 4.63x.

Compare with others

Compare:

Bombay Super Hybrid Seeds IPO Vs Dr Lalchandani Labs IPO